Phosphodiesterase inhibitor for heart failure with preserved ejection fraction: A systematic review and meta-analysis
Saudi Pharmaceutical Journal(2022)
Abstract
PDE inhibitors did not effectively improve LV function, PAP, exercise capacity, and QOL in patients with HFpEF. However, they improved RV function with significant difference, suggesting that PDE inhibitors might be a promising option for HFpEF patients with RV dysfunction.
MoreTranslated text
Key words
Phosphodiesterase inhibitor,Heart failure with preserved ejection fraction,Right ventricular dysfunction,Meta-analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined